Stephen C. Groft, director of the NIH Office of Rare Diseases, said more information and better diagnostics are needed to improve clinical trials for rare diseases, which also often struggle to find enough participants. He said his group supports collaborative work at multiple sites with multiple researchers and is working to attract more researchers and industry interest to rare diseases.

Related Summaries